Epigenomics of Common Diseases

The 5th Epigenomics of Common Diseases conference will bring together
leading scientists from the fields of epigenomics, genetics and
bioinformatics to discuss the latest developments in this fast-moving
area.

Epigenetic variation plays an important role in disease processes and
provides a promising focus for disease prediction, prevention and
treatment. Technological advancements in the past few years have fuelled
a dramatic increase in the scale, breadth and availability of epigenomic
reference data. In addition, novel developments such as single cell
analysis and gene editing present exciting new opportunities.
Associations between epigenetic variation, a variety of risk factors and
the development of many diseases continue to emerge but causality has, in
many instances, not yet been established.

This meeting will focus on epigenomic studies across of a wide range of
common and other diseases, including approaches from a variety of
different disciplines. It will explore technological and methodological
developments and provide a forum to present and discuss recent advances
in epigenomics of relevance to human disease.

The conference will start at approximately 12.30 on Friday, 6 November
and close at approximately 13.00 on Monday, 9 November 2015.

Scientific sessions

• Epigenomics of disease
• Chromatin organisation
• Model systems: animal and cellular models
• Population epigenetics
• Clinical epigenetics
• Single cell epigenetics
• Epigenetic engineering
• Informatics and technology

Scientific programme committee
Stephan Beck University College London, UK
Susan Clark The Garvan Institute of Medical Research, Australia
Andy Feinberg Johns Hopkins University School of Medicine, USA
Edith Heard Institut Curie, France
Caroline Relton University of Bristol, UK

Keynote speakers
Greg Hannon CSHL, USA
Edith Heard Institut Curie, France

Confirmed speakers
Julie Ahringer University of Cambridge, UK
Adrian Bird University of Edinburgh, UK
Pilar Blancafort The University of Western Australia,
Australia
Philippe Collas University of Oslo, Norway
Manolis Dermitzakis University of Geneva, Switzerland
Peter DiMaggio Imperial College London, UK
Joe Ecker Salk Institute, USA
Janine Felix Erasmus MC, The Netherlands
Peter Fraser Babraham Institute, UK
Charles Gersbach Duke University, USA
Anita Göndör Karolinska Institutet, Sweden
Maja Jagodic Karolinska Institutet, Sweden
Charlotte Ling Lund University, Sweden
Thomas Rando Stanford University, USA
Anjana Rao La Jolla Institute, USA
Carmen Sapienza Temple University, USA
Oliver Stegle EMBL-EBI, UK
Sarah Teichmann EMBL-EBI, UK
Daniel Zilberman University of California, Berkeley, USA

Conference organiser
Laura Hubbard Wellcome Genome Campus, UK

Registration Fees:

The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
booked accommodation.

Registration deadline: Closed

Accommodation
Accommodation is provided for the nights of 6, 7 and 8 November 2015.
Please note: there is limited on-site accommodation and this will be
allocated on a first-come first-served basis. Therefore, early
registration is recommended.

If you wish to book onsite accommodation either side of the conference dates, please contact the Conference Centre directly.

Travel visas
Contact the conference organiser if you require a letter to support a
travel visa application. Note that letters will only be provided to
confirmed registrants.

Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
or longer.

Please visit the following websites for further information:
UK Border Agency website: www.ukba.homeoffice.gov.uk/visas-immigration/

Information for general visitors and business visitors: www.ukba.homeoffice.gov.uk/visas-immigration/visiting/business/business-activities/

A limited number of registration bursaries are available for PhD students
to attend this conference (up to 50% of the registration fee) from
Wellcome Genome Campus Scientific Conferences.

The following documents will need to be provided:

• Abstract
• CV
• Covering letter
• Letter from supervisor

To apply, please contact the conference organiser.

Bursary deadline: Closed

We welcome abstracts from all areas relevant to epigenetic and epigenomic
research. Several oral presentations will be chosen from the abstracts
submitted.

Please register prior to submitting your abstract. Please note: abstracts will only be considered from registered delegates.

The scientific programme committee will assess your abstract after the
deadline has passed and you will be notified whether you have been
selected for an oral or poster presentation.

Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-
portrait) of printed material. Accepted abstracts will appear in the
conference programme book and poster boards will be allocated at the
conference.

Abstract deadline: Closed

Abstract guidelines

• Format & Font: Prepare your abstract in Microsoft Word in 11-point Ariel Font.
• Title: The title should be concise and be in bold, sentence case.
• Author names: The presenting author’s name must be the first name to appear on the list of authors. Underline the name of the presenting author. For each author give the forename followed by the surname.
• Affiliations: Please list the authors and affiliations directly under the title, separated by one empty line, and followed on additional lines as necessary. Indicate each author’s affiliation with a superscript numeral following the surname.
• Abstract length: should not exceed one 1.5-spaced page. The total word limit is 400 words (to include title, authors, affiliations and abstract narrative).
• Abstract narrative: must be clear and concise. Clearly describe the problem you are addressing, the results to date and any conclusions you can draw from them, so that your abstract can be evaluated by the programme committee. Avoid saying in effect ‘a solution to XYZ problem will be presented’. Please ensure that your abstract is checked for correctness of spelling and grammar in advance of submission.
• Subheadings: Please avoid the use of subheadings in the abstract narrative.
• References: A separate list of references at the end of the abstract is not necessary.
• File name: should be the same as the surname of the presenting author.
• Download a sample abstract document (Microsoft Word), which can be used for formatting purposes.